News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
114,036 Results
Type
Article (4579)
Company Profile (19)
Press Release (109438)
Section
Business (33541)
Career Advice (115)
Deals (5407)
Drug Delivery (5)
Drug Development (6205)
Employer Resources (12)
FDA (3354)
Job Trends (2153)
News (49636)
Policy (4025)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
Academia (412)
Allergies (9)
Alliances (11547)
ALS (6)
Alzheimer's disease (340)
Antibody-drug conjugate (ADC) (5)
Approvals (3364)
Artificial intelligence (87)
Autoimmune disease (1)
Automation (6)
Bankruptcy (48)
Best Places to Work (1773)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (10)
Bladder cancer (12)
Brain cancer (5)
Breast cancer (69)
Cancer (450)
Cardiovascular disease (28)
Career advice (105)
Career pathing (1)
CAR-T (16)
Cell therapy (33)
Cervical cancer (7)
Clinical research (4888)
Collaboration (179)
Compensation (24)
COVID-19 (487)
C-suite (38)
Cystic fibrosis (9)
Data (279)
Decentralized trials (1)
Depression (7)
Diabetes (18)
Diagnostics (5820)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (14)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (10880)
Employer branding (2)
Employer resources (12)
Events (14576)
Executive appointments (118)
FDA (3552)
Featured Employer (2)
Fibrodysplasia Ossificans Progressiva (1)
Funding (128)
Gene editing (2)
Generative AI (8)
Gene therapy (15)
GLP-1 (43)
Government (637)
Guidances (7)
Healthcare (3144)
IgA nephropathy (1)
Immunology and inflammation (8)
Indications (2)
Infectious disease (517)
Inflammatory bowel disease (14)
Influenza (13)
Intellectual property (7)
Interviews (13)
IPO (1872)
IRA (1)
Job creations (426)
Job search strategy (100)
Kidney cancer (5)
Labor market (1)
Layoffs (26)
Leadership (1)
Legal (580)
Liver cancer (11)
Lung cancer (52)
Lymphoma (32)
Machine learning (1)
Management (3)
Manufacturing (47)
MASH (6)
Medical device (2622)
Medtech (2622)
Mergers & acquisitions (3625)
Metabolic disorders (36)
Multiple sclerosis (24)
NASH (3)
Neurodegenerative disease (12)
Neuropsychiatric disorders (2)
Neuroscience (409)
NextGen: Class of 2025 (821)
Non-profit (647)
Northern California (371)
Now hiring (2)
Obesity (13)
Opinion (13)
Ovarian cancer (21)
Pain (5)
Pancreatic cancer (10)
Parkinson's disease (18)
Partnered (3)
Patents (24)
Patient recruitment (13)
Peanut (4)
People (9599)
Pharmaceutical (1)
Phase I (1459)
Phase II (2063)
Phase III (1835)
Pipeline (137)
Policy (2)
Postmarket research (248)
Preclinical (657)
Press Release (12)
Prostate cancer (35)
Psychedelics (1)
Radiopharmaceuticals (120)
Rare diseases (37)
Real estate (920)
Recruiting (6)
Regulatory (3118)
Reports (10)
Research institute (463)
Resumes & cover letters (15)
Rett syndrome (1)
Schizophrenia (1)
Series A (15)
Series B (13)
Service/supplier (2)
Sickle cell disease (2)
Southern California (301)
Spinal muscular atrophy (10)
Sponsored (5)
Startups (663)
Stomach cancer (2)
Supply chain (6)
The Weekly (1)
United States (3307)
Vaccines (48)
Venture capitalists (6)
Weight loss (6)
Women's health (6)
Date
Last 7 days (109)
Last 30 days (381)
Last 365 days (5122)
2025 (1652)
2024 (5397)
2023 (6477)
2022 (10576)
2021 (9999)
2020 (9423)
2019 (6654)
2018 (5189)
2017 (5699)
2016 (5668)
2015 (6457)
2014 (4865)
2013 (4319)
2012 (4698)
2011 (4921)
2010 (4352)
Location
Africa (134)
Alabama (6)
Alaska (1)
Arizona (59)
Arkansas (2)
Asia (5429)
Australia (1268)
California (839)
Canada (270)
China (32)
Colorado (55)
Connecticut (63)
Delaware (6)
Europe (15502)
Florida (104)
Georgia (41)
Idaho (4)
Illinois (106)
India (5)
Indiana (37)
Iowa (4)
Japan (24)
Kansas (11)
Kentucky (4)
Louisiana (1)
Maine (20)
Maryland (103)
Massachusetts (424)
Michigan (64)
Minnesota (74)
Missouri (28)
Montana (4)
Nebraska (9)
Nevada (2)
New Hampshire (19)
New Jersey (150)
New Mexico (17)
New York (313)
North Carolina (186)
North Dakota (6)
Northern California (371)
Ohio (79)
Oklahoma (2)
Oregon (7)
Pennsylvania (98)
Rhode Island (5)
South America (158)
South Carolina (5)
Southern California (301)
Tennessee (32)
Texas (180)
Utah (84)
Virginia (38)
Washington D.C. (6)
Washington State (74)
Wisconsin (30)
114,036 Results for "cleveland diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology
April 23, 2025
·
3 min read
Press Releases
University Hospitals Cleveland Medical Center Activates AI for Early Lung Cancer Identification
April 2, 2025
·
4 min read
BioMidwest
Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing Platform
Cleveland Diagnostics, Inc. announced the closing of over $75M in growth capital financing.
January 17, 2024
·
4 min read
BioMidwest
Masimo and Cleveland Clinic Collaborate to Improve Hospital Remote Care
Masimo, a leading global provider of medical technology and hospital automation solutions, and Cleveland Clinic, a nonprofit academic medical center, announced the launch of a new partnership centered around hospital-based remote patient monitoring, including TeleCritical Care.
June 27, 2024
·
10 min read
BioMidwest
Cleveland Diagnostics Announces Prostate Cancer Awareness Month Campaign: ‘A PSA on PSA’
Cleveland Diagnostics, Inc., a leading commercial-stage biotechnology company, is launching its inaugural Prostate Cancer Awareness Campaign this September: ‘A PSA on PSA.’
August 30, 2023
·
3 min read
Genetown
Life Molecular Imaging and SOFIE announce Neuraceq® availability in Cleveland
Life Molecular Imaging and SOFIE Biosciences, a national US manufacturer and developer of PET radiopharmaceuticals, announce that the companies have expanded their strategic partnership and licensing agreement to provide and distribute Neuraceq® out of SOFIE’s radiopharmaceutical manufacturing site located in Cleveland, Ohio.
April 5, 2024
·
5 min read
BioMidwest
Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test
Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has opened a new, state-of-the-art facility.
June 28, 2023
·
3 min read
Biotech Bay
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
Anixa Biosciences, Inc., a clinical-stage biotechnology company focused on the treatment and prevention of cancer, announced that it has entered into a joint development agreement with Cleveland Clinic to develop novel vaccines for various cancer types.
May 8, 2024
·
5 min read
Drug Development
TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
TFF Pharmaceuticals, Inc today announced that, in collaboration with Cleveland Clinic, the Company is advancing multiple multivalent universal influenza vaccines to protect against seasonal and pandemic viruses into preclinical testing.
May 20, 2024
·
7 min read
Business
Cleveland Diagnostics Announces Agreement with Quest Diagnostics to Expand Patient Access to IsoPSA® Prostate Cancer Testing
Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, today announced an agreement designed to expand patient access to Cleveland Diagnostics’ novel prostate cancer test, IsoPSA.
February 13, 2023
·
5 min read
1 of 11,404
Next
